By performing a screen for proteins in pre-operative and post-operative serum from men with high-risk prostate cancer, we identified CASP8, MSLN, FGFBP1, ICOSLG, TIE2, and S100A4 proteins as candidate biomarkers for high-risk prostate cancer. This evidence concerns the gene FGFBP1 and prostate cancer.